abstract |
The present invention relates to novel compounds of formula (Ia), or stereoisomeric forms thereof, mixtures of stereoisomeric forms thereof in all ratios, or physiologically acceptable salts thereof: Ia In the above formula (Ia) The substituents are as described in the present invention. The compounds of the present invention have CXCR5 inhibitory activity and are useful for the treatment or prevention of various inflammatory diseases associated with the modulation of human CXCR5 receptors, particularly rheumatoid arthritis, multiple sclerosis, lupus, Crohn's disease. |